Published in Res Dev Disabil on January 11, 2012
A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability. Res Dev Disabil (2014) 0.87
Financial and employment impact of intellectual disability on families of children with autism. Fam Syst Health (2015) 0.80
Health promotion and disease prevention strategies in older adults with intellectual and developmental disabilities. Front Public Health (2014) 0.80
Autologous cord blood therapy for infantile cerebral palsy: from bench to bedside. Obstet Gynecol Int (2014) 0.80
Developmental level and psychopathology: comparing children with developmental delays to chronological and mental age matched controls. Res Dev Disabil (2014) 0.75
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Pyruvate oxidation in brain: Some dialysable components of the pyruvate oxidation system. Biochem J (1939) 8.82
Pyruvate oxidation in brain: The active form of vitamin B(1) and the role of C(4) dicarboxylic acids. Biochem J (1939) 7.20
Translation of the genetic message: factors involved in the initiation of protein synthesis. Proc Natl Acad Sci U S A (1966) 3.54
Peptide synthesis by prokaryotic-eukaryotic hybrid ribosomes. J Biol Chem (1972) 2.84
Toxaemia and carbohydrate metabolism. J Physiol (1934) 2.80
Translation of the genetic message, ii. Effect of initiation factors on the binding of formyl-methionyl-trna to ribosomes. Proc Natl Acad Sci U S A (1967) 2.73
The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl (2003) 2.63
Synthesis of virus-specific proteins in Escherichia coli infected with the RNA bacteriophage MS2. Eur J Biochem (1967) 2.56
Translation of the genetic message. VII. Role of initiation factors in formation of the chain initiation complex with Escherichia coli ribosomes. Arch Biochem Biophys (1968) 2.46
Direction of reading of the genetic message. J Biol Chem (1965) 2.43
Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Res (1997) 2.30
MAMMALIAN METHYLMALONYL ISOMERASE AND VITAMIN B(12) COENZYMES. Proc Natl Acad Sci U S A (1960) 2.30
A supernatant factor involved in initiation complex formation with eukaryotic ribosomes. Proc Natl Acad Sci U S A (1971) 2.12
Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis (1994) 2.04
Regulation of protein synthesis initiation in eucaryotes. Arch Biochem Biophys (1983) 2.00
[Impact of the premature discharge on hospital mortality after a stay in an intensive care unit]. Med Intensiva (2011) 1.95
Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med (1989) 1.94
Mechanism of polypeptide chain initiation in eukaryotes and its control by phosphorylation of the alpha subunit of initiation factor 2. Proc Natl Acad Sci U S A (1982) 1.78
Mode of action of the hemin-controlled inhibitor of protein synthesis. Proc Natl Acad Sci U S A (1978) 1.75
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (1999) 1.74
Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis (1996) 1.61
Mechanism of translational control by partial phosphorylation of the alpha subunit of eukaryotic initiation factor 2. Proc Natl Acad Sci U S A (1984) 1.57
Mode of action of the hemin-controlled inhibitor of protein synthesis: studies with factors from rabbit reticulocytes. Proc Natl Acad Sci U S A (1978) 1.54
A protein binding the methylated 5'-terminal sequence, m7GpppN, of eukaryotic messenger RNA. Proc Natl Acad Sci U S A (1976) 1.54
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis. J Intern Med (2007) 1.53
Assessment of remission in schizophrenia with the CGI and CGI-SCH scales. Acta Psychiatr Scand (2007) 1.48
Further studies on the mode of action of the heme-controlled translational inhibitor. Proc Natl Acad Sci U S A (1979) 1.46
Role of 3':5'-cyclic-AMP-dependent protein kinase in regulation of protein synthesis in reticulocyte lysates. Proc Natl Acad Sci U S A (1977) 1.45
Regulation of protein synthesis in eukaryotes. Annu Rev Biochem (1979) 1.44
Direction of reading of the genetic message. II. Proc Natl Acad Sci U S A (1966) 1.44
Soluble factors required for eukaryotic protein synthesis. Annu Rev Biochem (1976) 1.42
Mode of action of the heme-controlled translational inhibitor: relationship of eukaryotic initiation factor 2-stimulating protein to translation restoring factor. Proc Natl Acad Sci U S A (1981) 1.42
[Evaluation of the quality of life in patients with HIV and AIDS infection]. Med Clin (Barc) (1999) 1.40
[Preliminary results of DERMATEL: prospective randomized study comparing synchronous and asynchronous modalities of teledermatology]. Actas Dermosifiliogr (2006) 1.39
[Biliary acute pancreatitis: an etiopathology and evolution review of 148 cases]. Acta Gastroenterol Latinoam (2000) 1.39
[Severe gastrointestinal complications potentially associated with the use of non-steroidal anti-inflammatory agents: hospital treatment costs for the National Health System of our country]. An Med Interna (2001) 1.39
A study of chemical changes associated with muscular contraction in normal and adrenalectomized animals. J Physiol (1934) 1.39
Mechanism of translational control by hemin in reticulocyte lysates. Proc Natl Acad Sci U S A (1977) 1.36
Effect of development on the translation of messenger RNA in Artemia salina embryos. Proc Natl Acad Sci U S A (1974) 1.35
Purification and properties of initiation factor F3. Nature (1970) 1.35
Translation of the genetic message. Naturwissenschaften (1968) 1.35
BIOTIN AND PROPIONYL CARBOXYLASE. Proc Natl Acad Sci U S A (1960) 1.32
Polypeptide chain initiation in E. coli: isolation of homogeneous initiation factor E2 and its relation to ribosomal proteins. Proc Natl Acad Sci U S A (1969) 1.31
Translation of the genetic message, iii. Formylmethionine as initiator of proteins programed by polycistronic messenger RNA. Proc Natl Acad Sci U S A (1967) 1.30
Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer (1991) 1.28
Chronic nervous-system effects of long-term occupational exposure to DDT. Lancet (2001) 1.28
Translation of the genetic message. V. Effect of Mg++ and formylation of methionine in protein synthesis. Proc Natl Acad Sci U S A (1967) 1.27
Purification of eukaryotic initiation factor 1 (EIF1) from Artemia salina embryos. Methods Enzymol (1974) 1.27
Messenger discriminating species of initiation factor F3. Nat New Biol (1971) 1.25
mRNA methylation and protein synthesis in extracts from embryos of brine shrimp, Artemia salina. J Biol Chem (1975) 1.24
Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion. Leukemia (2001) 1.22
Widening social inequalities in smoking cessation in Spain, 1987-1997. J Epidemiol Community Health (2001) 1.22
Transmucosal macromolecular drug delivery. J Control Release (2005) 1.22
Polypeptide chain initiation in eukaryotes: initiation factor MP in Artemia salina embryos. Proc Natl Acad Sci U S A (1975) 1.19
Training model for teaching endoscopic submucosal dissection of gastric tumors. Rev Esp Enferm Dig (2009) 1.19
Replication of phage RNA. Prog Nucleic Acid Res Mol Biol (1967) 1.15
Lack of a specific immune response against a recombinant capsid protein of Jaagsiekte sheep retrovirus in sheep and goats naturally affected by enzootic nasal tumour or sheep pulmonary adenomatosis. Vet Immunol Immunopathol (1998) 1.13
Virus-specific proteins in Escherichia coli infected with phage Qb. Biochim Biophys Acta (1969) 1.12
Purification and properties of two messenger-discriminating species of E. coli initiation factor 3. Arch Biochem Biophys (1973) 1.11
Dermoscopic features of a collision tumour composed of a pigmented basal cell carcinoma and a melanoma. J Eur Acad Dermatol Venereol (2010) 1.11
Virus-specific proteins in Escherichia coli infected with some amber mutants of phage MS2. Biochim Biophys Acta (1968) 1.10
Polypeptide chain initiation in eukaryotes: functional identity of supernatant factor from various sources. Proc Natl Acad Sci U S A (1972) 1.10
Specific inhibitors of MS2 and late T4 RNA translation in E. coli. Biochem Biophys Res Commun (1972) 1.09
Polypeptide chain initiation in eukaryotes. IV. Purification and properties of supernatant initiation factor from Artemia salina embryos. J Mol Biol (1973) 1.09
Polypeptide chain initiation in E. coli: studies on the function of initiation factor F1. Proc Natl Acad Sci U S A (1969) 1.09
A community outbreak of Legionnaires' disease associated with a cooling tower in Vic and Gurb, Catalonia (Spain) in 2005. Eur J Clin Microbiol Infect Dis (2008) 1.08
Sphere to rod transitions in homologous alkylpyridinium salts: a Stauff-Klevens-type equation for the second critical micelle concentration. J Colloid Interface Sci (2005) 1.08
Molecular characterization of the Mycoplasma gallisepticum pvpA gene which encodes a putative variable cytadhesin protein. Infect Immun (2000) 1.08
Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol (1998) 1.07
Polypeptide chain initiation in eukaryotes: reversibility of the ternary complex-forming reaction. Proc Natl Acad Sci U S A (1983) 1.07
Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. J Neuroimmunol (1999) 1.07
Influence of gender on social outcome in schizophrenia. Acta Psychiatr Scand (2002) 1.06
Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci (1997) 1.06
Polypeptide chain initiation in eukaryotes: mechanism of formation of initiation complex. Proc Natl Acad Sci U S A (1976) 1.05
Decrease in thyrocalcitonin-containing cells and analysis of other congenital anomalies in 11 patients with DiGeorge anomaly. Am J Med Genet (1993) 1.05
Isolation and properties of crystalline initiation factor F1 from Escherichia coli ribosomes. Eur J Biochem (1971) 1.05
Men who pay for sex in Spain and condom use: prevalence and correlates in a representative sample of the general population. Sex Transm Infect (2008) 1.01
Further studies on the mode of action of the heme-controlled translational inhibitor: stimulating protein acts at level of binary complex formation. Proc Natl Acad Sci U S A (1979) 1.01
Usefulness of currently available methods for the diagnosis of Anisakis simplex allergy. Allergy (2000) 1.01
Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol Lett (1995) 1.00
Atrophic dermatofibroma accompanied by aneurysmatic characteristics. J Eur Acad Dermatol Venereol (2006) 0.99
Gender differences and outcome in schizophrenia: a 2-year follow-up study in a large community sample. Eur Psychiatry (2003) 0.99
Nuclear localization of diguanosine polyphosphates in Artemia embryos. Arch Biochem Biophys (1971) 0.99
Purification and properties of the double-stranded RNA-activated eukaryotic initiation factor 3 kinase from rabbit reticulocytes. Proc Natl Acad Sci U S A (1980) 0.99
Mortality attributable to passive smoking in Spain, 2002. Tob Control (2007) 0.99
Translation of the genetic message, IV. UAA as a chain termination codon. Proc Natl Acad Sci U S A (1967) 0.99
X-linked ichthyosis along with recessive dystrophic epidermolysis bullosa in the same patient. Dermatology (2010) 0.98
Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus. FEBS Lett (1998) 0.98
Polypeptide chain initiation in E. coli: sulfhydryl groups and the function of initiation factor F2. Proc Natl Acad Sci U S A (1969) 0.98
Sex and age diagnosis by ischium morphometric analysis. Forensic Sci Int (2003) 0.98
Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. Biochim Biophys Acta (2001) 0.97
Clinical and endocrine spectrum in patients with the 45,X/46,XY karyotype. Hum Genet (1981) 0.97
Fragile sites in human and Macaca fascicularis chromosomes are breakpoints in chromosome evolution. Chromosome Res (2002) 0.97
Conformational control of the interaction of eukaryotic elongation factors EF-1 and EF-2 with ribosomes. Proc Natl Acad Sci U S A (1973) 0.97
Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol (2006) 0.97
Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity. Arch Intern Med (2001) 0.97
[Giant dermatofibroma: case report and review of the literature]. Actas Dermosifiliogr (2007) 0.96
Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats. Am J Physiol (1999) 0.96
Isolation of Mycoplasma hominis from extragenital cultures. Eur J Clin Microbiol Infect Dis (2005) 0.96